VISIT US IN CHICAGO JUNE 2-4 AT BOOTH 2073!

The 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology

Published: Saturday, Sep 08, 2012

Chicago, ILThe 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology, was held at the Marriott Downtown Chicago Magnificent Mile Hotel from September 6-8, 2012. Sessions at the symposium discussed utilizing a multidisciplinary treatment approach for the treatment of thoracic cancers. The meeting fostered interaction and the exchange of ideas between surgeons, medical oncologists, and radiation specialists.

Sessions at the conference contained information from speakers from around the world who discussed their recent clinical trials and research. Topics included a variety of strategies to treat lung and esophageal cancer, malignant mesothelioma, and metastatic cancers of the chest. In addition, the symposium highlighted the translation of novel clinically significant discoveries into clinical practice. Other topics examined molecular diagnoses, pathology, and the clinical significance of targeted therapies in molecularly defined patients and the selection of subpopulations for clinical trials.

<<< View coverage from the 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology

Chicago, ILThe 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology, was held at the Marriott Downtown Chicago Magnificent Mile Hotel from September 6-8, 2012. Sessions at the symposium discussed utilizing a multidisciplinary treatment approach for the treatment of thoracic cancers. The meeting fostered interaction and the exchange of ideas between surgeons, medical oncologists, and radiation specialists.

Sessions at the conference contained information from speakers from around the world who discussed their recent clinical trials and research. Topics included a variety of strategies to treat lung and esophageal cancer, malignant mesothelioma, and metastatic cancers of the chest. In addition, the symposium highlighted the translation of novel clinically significant discoveries into clinical practice. Other topics examined molecular diagnoses, pathology, and the clinical significance of targeted therapies in molecularly defined patients and the selection of subpopulations for clinical trials.

<<< View coverage from the 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
34th Annual Miami Breast Cancer Conference® Clinical Case Vignette Series™May 25, 20182.0
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Publication Bottom Border
Border Publication
x